Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Background: Glucose variability is one of components of the dysglycemia in diabetes and may play an important role in development of diabetic vascular complications. The objective of this study was to assess the relationship between glycemic variability determined by a continuous glucose monitoring (CGM) system and the presence and severity of coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM). Methods: In 344 T2DM patients with chest pain, coronary angiography revealed CAD (coronary stenosis ≥ 50% luminal diameter narrowing) in 252 patients and 92 patients without CAD. Gensini score was used to assess the severity of CAD. All participants' CGM parameters and biochemical characteristics were measured at baseline. Results: Diabetic patients with CAD were older, and more were male and cigarette smokers compared with the controls. Levels of the mean amplitude of glycemic excursions (MAGE) (3.7 ± 1.4 mmol/L vs. 3.2 ± 1.2 mmol/L, p < 0.001), postprandial glucose excursion (PPGE) (3.9 ± 1.6 mmol/L vs. 3.6 ± 1.4 mmol/L, p = 0.036), serum high-sensitive C-reactive protein (hs-CRP) (10.7 ± 12.4 mg/L vs. 5.8 ± 6.7 mg/L, p < 0.001) and creatinine (Cr) (87 ± 23 mmol/L vs. 77 ± 14 mmol/L, p < 0.001) were significantly higher in patients with CAD than in patients without CAD. Gensini score closely correlated with age, MAGE, PPGE, hemoglobin A 1c(HbA 1c), hs-CRP and total cholesterol (TC). Multivariate analysis indicated that age (p < 0.001), MAGE (p < 0.001), serum levels of HbA 1c(p = 0.022) and hs-CRP (p = 0.005) were independent determinants for Gensini score. Logistic regression analysis revealed that MAGE ≥ 3.4 mmol/L was an independent predictor for CAD. The area under the receiver-operating characteristic curve for MAGE (0.618, p = 0.001) was superior to that for HbA 1c(0.554, p = 0.129). Conclusions: The intraday glycemic variability is associated with the presence and severity of CAD in patients with T2DM. Effects of glycemic excursions on vascular complications should not be neglected in diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s5 · Cited by 1,666
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., & Giugliano, D. (2008) · Diabetes · doi:10.2337/db08-0063 · Cited by 1,310
Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., & Parrott, M. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.436 · Cited by 1,130
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Diabetes Care · doi:10.2337/dc07-9917 · Cited by 1,055
Khaw, K.-T., Wareham, N., Bingham, S., Luben, R., Welch, A., & Day, N. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00006 · Cited by 974
Hanefeld, M., Fischer, S., Julius, U., Schulze, J., Schwanebeck, U., Schmechel, H., Ziegelasch, H. J., & Lindner, J. (1996) · Diabetologia · doi:10.1007/s001250050617 · Cited by 873
Avolio, A. P., Deng, F. Q., Li, W. Q., Luo, Y. F., Huang, Z. D., Xing, L. F., & O'Rourke, M. F. (1985) · Circulation · doi:10.1161/01.cir.71.2.202 · Cited by 839
Quagliaro, L., Piconi, L., Assaloni, R., Martinelli, L., Motz, E., & Ceriello, A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2795 · Cited by 769
Glycemic variability: A strong independent predictor of mortality in critically ill patients.
Krinsley, J. S. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818b38d2 · Cited by 729
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179294 · Cited by 638
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Temelkova-Kurktschiev, T. S., Koehler, C., Henkel, E., Leonhardt, W., Fuecker, K., & Hanefeld, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1830 · Cited by 544
Glycemic Variability: A Hemoglobin A1c–Independent Risk Factor for Diabetic Complications
Brownlee, M., & Hirsch, I. B. (2006) · JAMA · doi:10.1001/jama.295.14.1707 · Cited by 482
Glucose Variability; Does It Matter?
Siegelaar, S. E., Holleman, F., Hoekstra, J. B. L., & DeVries, J. H. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0021 · Cited by 409
The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2006) · Diabetes Care · doi:10.2337/dc06-0293 · Cited by 377
Monnier, L., Colette, C., & Owens, D. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200618 · Cited by 294
Monnier, L., & Colette, C. (2008) · Diabetes Care · doi:10.2337/dc08-s241 · Cited by 263
Muggeo, M., Zoppini, G., Bonora, E., Brun, E., Bonadonna, R. C., Moghetti, P., & Verlato, G. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.45 · Cited by 263
Hirshberg, E., Larsen, G., & Van Duker, H. (2008) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e318172d401 · Cited by 202
Blood glucose variability is associated with mortality in the surgical intensive care unit
Dossett, L. A., Cao, H., Mowery, N. T., Dortch, M. J., Morris, J. M., & May, A. K. (2008) · The American Surgeon™ · doi:10.1177/000313480807400802 · Cited by 190
Hou, Z., Li, H., Gao, L., Pan, L., Zhao, J., & Li, G. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.03.004 · Cited by 78
Type 2 diabetes, cardiovascular risk, and the link to insulin resistance
STOLAR, M. W., & CHILTON, R. J. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80240-0 · Cited by 77
Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients
Gimeno-Orna, J. A., Castro-Alonso, F. J., Juliani, B. B., & Lou-Arnal, L. M. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00197-6 · Cited by 72
Hu, Y., Liu, W., Huang, R., & Zhang, X. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.11.015 · Cited by 69
For debate.Glucose variability and diabetes complication risk: we need to know the answer
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02929.x · Cited by 57
How should HbA1c measurements be reported?
Gorus, F., Mathieu, C., & Gerlo, E. (2005) · Diabetologia · doi:10.1007/s00125-005-0073-7 · Cited by 44
Takei, Y., Tomiyama, H., Tanaka, N., & Yamashina, A. (2007) · Circulation Journal · doi:10.1253/circj.71.202 · Cited by 42
Insulin resistance and circadian rhythm of cardiac autonomic modulation
Rodriguez-Colon, S. M., Li, X., Shaffer, M. L., He, F., Bixler, E. O., Vgontzas, A. N., Cai, J., & Liao, D. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-85 · Cited by 32
The Effect of Glucose Fluctuation on Apoptosis and Function of INS-1 Pancreatic Beta Cells
Kim, M.-K., Jung, H. S., Yoon, C. S., Ko, J. H., Jun, H. J., Kim, T. K., Kwon, M. J., Lee, S. H., Ko, K. S., Rhee, B. D., et al. (2010) · Korean Diabetes Journal · doi:10.4093/kdj.2010.34.1.47 · Cited by 31
Gupta, A., Cornélissen, G., Greenway, F. L., Dhoopati, V., Halberg, F., & Johnson, W. D. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-58 · Cited by 29
Siegelaar, S. E., Kulik, W., van LENTHE, H., Mukherjee, R., Hoekstra, J. B. L., & DeVries, J. H. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01037.x · Cited by 25
Group of Signs: A New Method to Evaluate Glycemic Variability
Zaccardi, F., Stefano, P. D., Busetto, E., Federici, M. O., Manto, A., Infusino, F., Lanza, G. A., Pitocco, D., & Ghirlanda, G. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200614 · Cited by 23
Cited by
Lu, J., Ma, X., Zhou, J., Zhang, L., Mo, Y., Ying, L., Lu, W., Zhu, W., Bao, Y., Vigersky, R. A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1131 · Cited by 517
Papachristoforou, E., Lambadiari, V., Maratou, E., & Makrilakis, K. (2020) · Journal of Diabetes Research · doi:10.1155/2020/7489795 · Cited by 479
Yapanis, M., James, S., Craig, M. E., O’Neal, D., & Ekinci, E. I. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac034 · Cited by 291
Torimoto, K., Okada, Y., Mori, H., & Tanaka, Y. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-1 · Cited by 284
Xu, F., Zhao, L.-H., Su, J.-B., Chen, T., Wang, X.-Q., Chen, J.-F., Wu, G., Jin, Y., & Wang, X.-H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-139 · Cited by 159
Self-citation
Metadata
- Authors
- Su, G., Mi, S., Tao, H., Li, Z., Yang, H., Zheng, H., Zhou, Y., & Ma, C.
- Venue
- Cardiovascular Diabetology
- Published
- 2011-02-25
- Volume
- 10
- Issue
- 1
- Pages
- 19-19
- ISSN
- 1475-2840 (ISSN-L)
- OpenAlex
- W2120175636
- Cited by
- 257
- References
- 39
- FWCI
- 12.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.